SCP
ARLZ

Silverleafe Capital Partners’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Silverleafe Capital Partners’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-100,000
Closed -$35K – 68
2018
Q2 		$35K Buy
+100,000
New +$82K 0.02% 62

Other funds holding ARLZ

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Silverleafe Capital Partners's ARLZ Position: Q3 2018 in Review

Silverleafe Capital Partners sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 100,000 shares — an estimated $35K sold.

Silverleafe Capital Partners first reported a position in ARLZ in Q2 2018 and held it in 1 quarter. The position peaked at $35K in Q2 2018. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

  • Silverleafe Capital Partners reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Silverleafe Capital Partners sold 100,000 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $35K.
  • Silverleafe Capital Partners first reported a position in Aralez Pharmaceuticals Inc. in Q2 2018 and held it in 1 quarter.
  • Silverleafe Capital Partners's Aralez Pharmaceuticals Inc. position peaked at $35K in Q2 2018.
  • 4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Silverleafe Capital Partners's 13F filing for Q3 2018, filed 5 Oct 2018.